We serve Chemical Name:5-Hexyn-3-ol CAS:19780-84-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Hexyn-3-ol
CAS.NO:19780-84-8
Synonyms:Hex-5-yn-3-ol;MFCD00041593;5-Hexyn-3-ol;3-hydroxyhex-5-yne;hex-1-yn-4-ol;4-Hydroxy-1-hexyne;EINECS 243-304-0;1-Hexyn-4-ol;AJYGRAORQSCNED-UHFFFAOYSA;4-hydroxyhex-1-yne
Molecular Formula:C6H10O
Molecular Weight:98.143
HS Code:2905290000
Physical and Chemical Properties:
Melting point:-34°C (estimate)
Boiling point:162.6±13.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.447
PSA:20.23000
Exact Mass:98.073166
LogP:0.87
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1987
Packing Group:III
Contact us for information like Hex-5-yn-3-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-hydroxyhex-1-yne physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Hexyn-4-ol Use and application,3-hydroxyhex-5-yne technical grade,usp/ep/jp grade.
Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 5-Hexyn-3-ol manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 5-Hexyn-3-ol supplier But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 5-Hexyn-3-ol vendor Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 5-Hexyn-3-ol factory The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.
